20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction

Free Radical Biology and Medicine

Volumn 46, Issue 2, 2009, Pages 263-270

  Tsai, I Jung ^a   Croft, Kevin D ^a   Mori, Trevor A ^a   Falck, John R ^b   Beilin, Lawrence J ^a   Puddey, Ian B ^a   Barden, Anne E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

F2 isoprostanes; Free radicals; Metabolic syndrome; Plasma and urinary 20 HETE; Weight reduction

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; GAMMA GLUTAMYLTRANSFERASE; ISOPROSTANE DERIVATIVE; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; BIOLOGICAL MARKER; HYDROXYICOSATETRAENOIC ACID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROLYTE URINE LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; HEALTH PROGRAM; HUMAN; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; URINE LEVEL; WEIGHT CONTROL; WEIGHT REDUCTION; AGED; BLOOD; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; HYPERTENSION; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; URINE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; F2-ISOPROSTANES; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; RISK FACTORS; WEIGHT LOSS;

EID: 58049120210     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.10.028     Document Type: Article

References (44)

1. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 (2002) 131-185
2. Roberts L.J., and Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28 (2000) 505-513
3. Elbekai R.H., and El-Kadi A.O.S. Cytochrome p450enzymes: central players in cardiovascular health and disease. Pharmacol. Ther. 112 (2006) 564-587
4. Wang M.H., Guan H., Nguyen X., Zand B.A., Nasjletti A., and Laniado-Schwartzman M. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am. J. Physiol. 276 2 Pt 2 (1999) F246-F253
5. Wang M.H., Zhang F., Marji J., Zand B.A., Nasjletti A., and Laniado-Schwartzman M. CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R255-R261
6. Sacerdoti D., Escalante B., Abraham N.G., McGiff J.C., Levere R.D., and Schwartzman M.L. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243 (1989) 388-390
7. Wang J.S., Singh H., Zhang F., Ishizuka T., Deng H., Kemp R., Wolin M.S., Hintze T.H., Abraham N.G., Nasjletti A., and Laniado-Schwartzman M. Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ. Res. 98 (2006) 962-969
8. Roman R.J., Hoagland K.M., Lopez B., Kweitek A.E., Garrett M.R., Rapp J.P., Lazar J., Jacob H.J., and Sarkis A. Characterisation of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats. Am. J. Physiol. 290 (2006) F1463-F147
9. Hoagland K.M., Flasch A.K., and Roman R.J. Blockade of renal 20-HETE formation promotes salt sensitive hypertension in rats. Hypertension 42 (2003) 669-673
10. Laffer C.L., Laniado-Schwartzman M., Wang M., Nasjletti A., and Elijovich F. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension. Circulation 107 (2003) 574-578
11. Gonzalez F.J. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res. 569 (2005) 101-110
12. Puntarulo S., and Cederbaum A.I. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free. Radic. Biol. Med. 24 (1998) 1324-1330
13. Fleming I., Michaelis U.R., Bredenkotter D., Fisslthaler B., Dehghani F., Brandes R.P., and Busse R. Endothelium derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ. Res. 88 (2001) 44-51
14. Medhora M.M., Chen Y., Gruenloh S.K., Harland D., Bodiga S., Zielonka J., Gebremedhin G., Gao Y., Falck J.R., Anjaiah S., and Jacobs E.R. 20 HETE increases superoxide production and activates NADPH oxidase in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 294 (2008) L902-L911
15. Ward N.C., Puddey I.B., Hodgson J.M., Beilin L.J., and Croft K.D. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic. Biol. Med. 38 (2005) 1032-1036
16. Barden A., Zilkens R.R., Croft K.D., Mori T.A., Burke V., Beilin L.J., and Puddey I.B. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. Free Radic. Biol. Med. 42 (2007) 1730-1735
17. Ward N.C., Rivera J., Hodgson J., Puddey I.B., Beilin L.J., Falck J.R., and Croft K.D. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 110 (2004) 438-443
18. Laffer C.L., Laniado-Schwartzman M., Nasjletti A., and Elijovich F. 20-HETE and circulating insulin in essential hypertension with obesity. Hypertension 43 (2004) 388-392
19. Van Guilder G.P., Hoetzer G.L., Greiner J.J., Stauffer B.L., and Desouza C.A. Influence of the metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 14 (2006) 2127-2131
20. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M.J., and Kontush A. The metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J. Clin. Endocrinol. Metab. 89 (2004) 4963-4971
21. Palmieri V.O., Grattagliano I., Portincasa P., and Palasciano G. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J. Nutr. 136 (2006) 3022-3026
22. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., Taskinen M.R., and Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
23. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., and Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
24. Zieve F.J. The metabolic syndrome: diagnosis and treatment. Clin. Cornerstone 6 (2004) S5-S13
25. Executive summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
26. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N.O., Best J.D., and Beilin L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 71 (2000) 1085-1094
27. Rivera J., Ward N.C., Hodgson J., Puddey I.B., Falck J.R., and Croft K.D. Measurement of 20-hydroxyeicosatrienoic acid in human urine by gas chromatography-mass spectrometry. Clin. Chem. 50 (2004) 224-226
28. Mori T.A., Croft K.D., Puddey I.B., and Beilin L.J. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal. Biochem. 268 (1999) 117-125
29. Oyekan A.O., McAward K., Conetta J., Rosenfeld L., and McGiff J.C. Endothelin1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension. Am. J. Physiol. Integr. Comp. Physiol. 276 (1999) 766-775
30. Alonso-Galicia M., Maier K.G., Greene A.S., Cowley A.W., and Roman R.R. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am. J. Physiol. Integr. Comp. Physiol. 283 (2002) R60-R68
31. Lasker J.M., Chen W.B., Wolf I., et al. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid in human kidney: role of Cyp4F2 and Cyp4a11. J. Biol. Chem. 275 (2000) 4118-4126
32. Schwartzman M.L., Martasek P., Rios A.R., et al. Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int. 37 (1990) 94-99
33. Prakash C., Zhang J.Y., Falck J.R., et al. 20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine. Biochem. Biophys. Res. Commun. 185 (1992) 728-733
34. McGiff J.C., and Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am. J. Physiol. 277 (1999) R607-R623
35. Cheng M.K., McGiff J.C., and Carroll M.A. Renal arterial 20-hydroxyeicosatetraenoic acid levels : regulation by cyclooxygenase. Am. J. Physiol. 284 (2003) F474-F479
36. Kaduce T.L., Fang X., Harmon S.D., Oltman C.L., Dellsperger K.C., Teesch L.M., Gopal V.R., Falck J.R., Campbell W.B., Weintraub N.L., and Spector A.A. 20-Hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. J. Biol. Chem. 279 (2004) 2648-2656
37. Li L., Fink G.D., Watts S.W., Northcott C.A., Galligan J.J., Pagano P.J., and Chen A.F. Endothelin-1 increases vascular superoxide via endothelin A-NADPH oxidase pathway in low-renin hypertension. Circulation 107 (2003) 1053-1058
38. Pierdomenico S.D., Costantini F., Bucci A., De Cesare D., Bucciarelli T., Cuccurullo F., and Mezzetti A. Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. Am. J. Hypertens. 12 (1999) 356-363
39. Lee D.H., Blomhoff R., and Jacobs D.R. Is serum γ-glutamyltransferase a marker of oxidative stress?. Free Radic. Res. 38 (2004) 535-539
40. Stec D.E., Deng A.Y., Rapp J.P., and Roman R.J. Inhibition of outer renal medullary 20-HETE production produces hypertension in Lewis rats. Hypertension 29 (1997) 315-319
41. Sankaralingam S., Desai K.M., Glaeser H., Kim R.B., and Wilson T.W. Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats. Am. J. Hypertens. 19 (2006) 1174-1880
42. Hoffmann I.S., and Cubeddu L.X. Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome. J. Hum. Hypertens. 21 (2007) 438-444
43. Hu G., Jousilahti P., Peltonen M., Lindstrom J., and Tuomilehto J. Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland. Diabetologia 48 (2005) 1477-1483
44. Johnson J.B., Summer W., Cutler R.G., Martin B., Hyun D.H., et al. Alternate day caloric restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic. Biol. Med. 42 (2007) 665-674